131 related articles for article (PubMed ID: 37252844)
1. DRD1 signaling modulates TrkB turnover and BDNF sensitivity in direct pathway striatal medium spiny neurons.
Andreska T; Lüningschrör P; Wolf D; McFleder RL; Ayon-Olivas M; Rattka M; Drechsler C; Perschin V; Blum R; Aufmkolk S; Granado N; Moratalla R; Sauer M; Monoranu C; Volkmann J; Ip CW; Stigloher C; Sendtner M
Cell Rep; 2023 Jun; 42(6):112575. PubMed ID: 37252844
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic Input Regulates the Sensitivity of Indirect Pathway Striatal Spiny Neurons to Brain-Derived Neurotrophic Factor.
Ayon-Olivas M; Wolf D; Andreska T; Granado N; Lüningschrör P; Ip CW; Moratalla R; Sendtner M
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887070
[TBL] [Abstract][Full Text] [Related]
3. BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia.
Pelosi A; Nakamura Y; Girault JA; Hervé D
Neurobiol Dis; 2023 Sep; 185():106238. PubMed ID: 37495178
[TBL] [Abstract][Full Text] [Related]
4. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
[TBL] [Abstract][Full Text] [Related]
5. Early Downregulation of p75
Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
[TBL] [Abstract][Full Text] [Related]
6. BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia.
Scheggi S; Rossi F; Corsi S; Fanni S; Tronci E; Ludovica C; Vargiu R; Gambarana C; Muñoz A; Stancampiano R; Björklund A; Carta M
J Parkinsons Dis; 2020; 10(4):1503-1514. PubMed ID: 32651332
[TBL] [Abstract][Full Text] [Related]
7. TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.
Ghiglieri V; Sgobio C; Patassini S; Bagetta V; Fejtova A; Giampà C; Marinucci S; Heyden A; Gundelfinger ED; Fusco FR; Calabresi P; Picconi B
Neuropsychopharmacology; 2010 Jun; 35(7):1531-40. PubMed ID: 20200504
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway.
Shen B; Zhang D; Zeng X; Guan L; Yang G; Liu L; Huang J; Li Y; Hong S; Li L
Psychopharmacology (Berl); 2022 May; 239(5):1521-1537. PubMed ID: 34997862
[TBL] [Abstract][Full Text] [Related]
9. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells.
Küppers E; Beyer C
Neuroreport; 2001 May; 12(6):1175-9. PubMed ID: 11338187
[TBL] [Abstract][Full Text] [Related]
10. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
11. Differential enhancement of ERK, PKA and Ca
Mariani LL; Longueville S; Girault JA; Hervé D; Gervasi N
Neurobiol Dis; 2019 Oct; 130():104506. PubMed ID: 31220556
[TBL] [Abstract][Full Text] [Related]
12. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
13. Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson's disease model.
Farrand AQ; Helke KL; Aponte-Cofresí L; Gooz MB; Gregory RA; Hinson VK; Boger HA
Behav Brain Res; 2019 Nov; 373():112080. PubMed ID: 31301412
[TBL] [Abstract][Full Text] [Related]
14. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
[TBL] [Abstract][Full Text] [Related]
15. Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.
Fieblinger T; Zanetti L; Sebastianutto I; Breger LS; Quintino L; Lockowandt M; Lundberg C; Cenci MA
Sci Rep; 2018 Jul; 8(1):10068. PubMed ID: 29968767
[TBL] [Abstract][Full Text] [Related]
16. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
[TBL] [Abstract][Full Text] [Related]
17. Pathway-Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease.
Tanimura A; Shen W; Wokosin D; Surmeier DJ
Mov Disord; 2022 Jun; 37(6):1164-1174. PubMed ID: 35485341
[TBL] [Abstract][Full Text] [Related]
18. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Głowacka U; Kuter K; Ossowska K
PLoS One; 2015; 10(3):e0117698. PubMed ID: 25739024
[TBL] [Abstract][Full Text] [Related]
19. Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development.
Li Y; Yui D; Luikart BW; McKay RM; Li Y; Rubenstein JL; Parada LF
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15491-6. PubMed ID: 22949667
[TBL] [Abstract][Full Text] [Related]
20. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
